Analyst Price Targets — SPPI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 3, 2023 11:17 am | — | Cantor Fitzgerald | $0.75 | $0.81 | Benzinga | Cantor Fitzgerald Maintains Neutral on Spectrum Pharmaceuticals, Lowers Price Target to $0.75 |
Latest News for SPPI
Kaplan Fox & Kilsheimer LLP Announces Proposed Class Action Settlement on Behalf of all Persons and Entities that Purchased the Common Stock of Spectrum Pharmaceuticals, Inc.
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that the United States District Court for the Southern District of New York has approved the following announcement of a proposed class action settlement that would benefit all persons and entities that purchased the Common Stock of Spectrum Pharmaceuticals, Inc.:
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SPPI.
U.S. House Trading
No House trades found for SPPI.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.